Researchers have finally seen and measured the tiny alpha-synuclein oligomers that may ignite Parkinson’s disease. With the ultra-sensitive ASA-PD imaging method, they captured these clusters in brain tissue, finding larger and more numerous versions in patients with Parkinson’s. The discovery could mark a turning point in diagnosing and treating the disease, revealing the first visible signs long before symptoms appear.
Researchers have finally seen and measured the tiny alpha-synuclein oligomers that may ignite Parkinson’s disease. With the ultra-sensitive ASA-PD imaging method, they captured these clusters in brain tissue, finding larger and more numerous versions in patients with Parkinson’s. The discovery could mark a turning point in diagnosing and treating the disease, revealing the first visible signs long before symptoms appear. Researchers have finally seen and measured the tiny alpha-synuclein oligomers that may ignite Parkinson’s disease. With the ultra-sensitive ASA-PD imaging method, they captured these clusters in brain tissue, finding larger and more numerous versions in patients with Parkinson’s. The discovery could mark a turning point in diagnosing and treating the disease, revealing the first visible signs long before symptoms appear.